Literature DB >> 11447046

Is open-angle glaucoma associated with early menopause? The Rotterdam Study.

C A Hulsman1, I C Westendorp, R S Ramrattan, R C Wolfs, J C Witteman, J R Vingerling, A Hofman, P T de Jong.   

Abstract

The authors examined the association between age at menopause and open-angle glaucoma among women aged > or = 55 years in the population-based Rotterdam Study (1990--1993). Information on age and type of menopause was obtained by interview. Subjects (n = 3,078) were stratified into three categories according to age at menopause: <45 years, 45--49 years, and > or = 50 years, with the last group serving as the reference group. Diagnosis of open-angle glaucoma was based on the presence of a glaucomatous visual field defect and glaucomatous optic neuropathy. Open-angle glaucoma was diagnosed in 78 women with a natural menopause and 15 women with an artificial menopause. In the category of natural menopause, women who went through menopause before reaching the age of 45 years had a higher risk of open-angle glaucoma than the reference group (odds ratio = 2.6; 95% confidence interval: 1.5, 4.8), after adjustment for age and use of hormone replacement therapy. Among women who went through menopause between the ages of 45 and 49 years, the odds ratio was 1.1 (95% confidence interval: 0.7, 2.0). These findings suggest that early menopause is associated with a higher risk of open-angle glaucoma.

Entities:  

Mesh:

Year:  2001        PMID: 11447046     DOI: 10.1093/aje/154.2.138

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  46 in total

1.  Female reproductive factors and open angle glaucoma: the Blue Mountains Eye Study.

Authors:  A J Lee; P Mitchell; E Rochtchina; P R Healey
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

2.  Menopause exacerbates visual dysfunction in experimental glaucoma.

Authors:  Andrew J Feola; Jieming Fu; Rachael Allen; Victoria Yang; Ian C Campbell; Amy Ottensmeyer; C Ross Ethier; Machelle Pardue
Journal:  Exp Eye Res       Date:  2019-06-18       Impact factor: 3.467

3.  Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma in Caucasians from the USA.

Authors:  Janey L Wiggs; Jae Hee Kang; Brian L Yaspan; Daniel B Mirel; Cathy Laurie; Andrew Crenshaw; Wendy Brodeur; Stephanie Gogarten; Lana M Olson; Wael Abdrabou; Elizabeth DelBono; Stephanie Loomis; Jonathan L Haines; Louis R Pasquale
Journal:  Hum Mol Genet       Date:  2011-08-26       Impact factor: 6.150

Review 4.  Ocular cytochrome P450s and transporters: roles in disease and endobiotic and xenobiotic disposition.

Authors:  Mariko Nakano; Catherine M Lockhart; Edward J Kelly; Allan E Rettie
Journal:  Drug Metab Rev       Date:  2014-05-26       Impact factor: 4.518

Review 5.  Eye diseases in women.

Authors:  Sakumi Kazama; Junichiro James Kazama; Noburo Ando
Journal:  Fukushima J Med Sci       Date:  2019-06-11

6.  A nested case control study of plasma ICAM-1, E-selectin and TNF receptor 2 levels, and incident primary open-angle glaucoma.

Authors:  Jae H Kang; Janey L Wiggs; Louis R Pasquale
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-11       Impact factor: 4.799

7.  The potential association between postmenopausal hormone use and primary open-angle glaucoma.

Authors:  Paula Anne Newman-Casey; Nidhi Talwar; Bin Nan; David C Musch; Louis R Pasquale; Joshua D Stein
Journal:  JAMA Ophthalmol       Date:  2014-03       Impact factor: 7.389

Review 8.  Is Estrogen a Therapeutic Target for Glaucoma?

Authors:  Samantha S Dewundara; Janey L Wiggs; David A Sullivan; Louis R Pasquale
Journal:  Semin Ophthalmol       Date:  2016       Impact factor: 1.975

Review 9.  Gender and glaucoma: what we know and what we need to know.

Authors:  Thasarat S Vajaranant; Sushma Nayak; Jacob T Wilensky; Charlotte E Joslin
Journal:  Curr Opin Ophthalmol       Date:  2010-03       Impact factor: 3.761

10.  Expression of estrogen receptor alpha and 17beta-hydroxysteroid dehydrogenase 4 in the ciliary body.

Authors:  Kaori Kobayashi; Ryo Iwakiri; Hiroshi Kobayashi; Satoshi Okinami
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-11-21       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.